In the Half Year they said:
![]()
Just thought some people may be interested in a clinical trial result published on the use of Tenecteplase in stroke patients which enrolled 458 patients. Its result concluded it did not result in better clinical outcomes. I thought people might be interested as I expect Clinuvel will eventually have to conduct a similar structured trial for Prenumbra.
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
Source: Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection | NEJM
Regards
SP
- Forums
- ASX - By Stock
- Ann: Positive Final Results in Stroke Study CUV801
In the Half Year they said: [ATTACH] Just thought some people...
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$14.05 |
Change
0.050(0.36%) |
Mkt cap ! $703.5M |
Open | High | Low | Value | Volume |
$14.00 | $14.07 | $13.89 | $342.4K | 24.49K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1250 | $13.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.05 | 97 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1250 | 13.990 |
1 | 213 | 13.970 |
1 | 213 | 13.950 |
1 | 213 | 13.930 |
1 | 213 | 13.900 |
Price($) | Vol. | No. |
---|---|---|
14.050 | 97 | 1 |
14.120 | 66 | 1 |
14.130 | 213 | 1 |
14.150 | 213 | 1 |
14.170 | 213 | 1 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |